Recap of the Prostate Cancer Clinical Trials Working Group 4 (PCWG4) update: patient-centred end points, molecular and imaging biomarkers for eligibility and response, PSMA PET/CT integration, revised radiographic progression and a 'no longer clinically benefitting' concept.
Guideline
Ravi Kumar et al. Prostate Cancer Working Group 4 Recap